C.M. Bidwell & Associates’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-3,815
Closed -$294K – 478
2018
Q3
$294K Buy
+3,815
New +$281K 0.28% 96

Other funds holding SGEN

C.M. Bidwell & Associates's SGEN Position: Q4 2018 in Review

C.M. Bidwell & Associates sold out of Seagen Inc. Common Stock (SGEN) in Q4 2018, closing a stake of 3,815 shares — an estimated $294K sold.

C.M. Bidwell & Associates first reported a position in SGEN in Q3 2018 and held it in 1 quarter. The position peaked at $294K in Q3 2018. 308 funds tracked by Wall St. Rank hold SGEN as of Q4 2018.

  • C.M. Bidwell & Associates reported no remaining Seagen Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 3,815 Seagen Inc. Common Stock shares in Q4 2018, an estimated $294K.
  • C.M. Bidwell & Associates first reported a position in Seagen Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • C.M. Bidwell & Associates's Seagen Inc. Common Stock position peaked at $294K in Q3 2018.
  • 308 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2018.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2018, filed 14 Feb 2019.